RankingsPricing
  1. JP-listed companies
  2. TRANS GENIC GROUP INC.
  3. Financials
  4. Capital expenditures

TRANS GENIC GROUP INC.【JP:2342】

Market cap
¥5.3B
P/E ratio
129.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-175-33.96%
Mar 31, 2024-266-13.26%
Mar 31, 2023-306-42.43%
Mar 31, 2022-532+264.90%
Mar 31, 2021-146-43.20%
Mar 31, 2020-257-19.90%
Mar 31, 2019-320+332.55%
Mar 31, 2018-74-41.70%
Mar 31, 2017-127+32.88%
Mar 31, 2016-96+118.84%
Mar 31, 2015-44

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)